The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 160, Issue 4, Pages 465-476
Publisher
Wiley
Online
2012-12-19
DOI
10.1111/bjh.12164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting heat shock factor 1 with a triazole nucleoside analog to elicit potent anticancer activity on drug-resistant pancreatic cancer
- (2012) Yi Xia et al. CANCER LETTERS
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
- (2012) L. Neckers et al. CLINICAL CANCER RESEARCH
- Triptolide: structural modifications, structure–activity relationships, bioactivities, clinical development and mechanisms
- (2012) Zhao-Li Zhou et al. NATURAL PRODUCT REPORTS
- A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease
- (2012) Peter O. Hofgaard et al. PLoS One
- Prosurvival role of heat shock factor 1 in the pathogenesis of pancreatobiliary tumors
- (2011) Vikas Dudeja et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study
- (2011) Paul G. Richardson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo
- (2011) Feng Fang et al. CANCER
- Expression of heat shock proteins in classical Hodgkin lymphoma: correlation with apoptotic pathways and prognostic significance
- (2011) Almudena Santón et al. HISTOPATHOLOGY
- Triptolide and its expanding multiple pharmacological functions
- (2011) Qiuyan Liu INTERNATIONAL IMMUNOPHARMACOLOGY
- MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML
- (2011) B Z Carter et al. LEUKEMIA
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Total synthesis of novel D-ring-modified triptolide analogues: structure–cytotoxic activity relationship studies on the D-ring of triptolide
- (2011) Bing Zhou et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
- (2011) S. Santagata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Implication of Heat Shock Factors in Tumorigenesis: Therapeutical Potential
- (2011) Aurelie De Thonel et al. Cancers
- Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585
- (2010) Thorsten Stühmer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma
- (2010) E L Davenport et al. LEUKEMIA
- Heat shock factors: integrators of cell stress, development and lifespan
- (2010) Malin Åkerfelt et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis
- (2010) L Meng et al. ONCOGENE
- Anti-myeloma activity of the novel 2-aminothienopyrimidine Hsp90 inhibitor NVP-BEP800
- (2009) Thorsten Stühmer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours
- (2009) J.J.E.M. Kitzen et al. EUROPEAN JOURNAL OF CANCER
- Inhibiting the transcription factor HSF1 as an anticancer strategy
- (2009) Luke Whitesell et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Triptolide is an inhibitor of RNA polymerase I and II-dependent transcription leading predominantly to down-regulation of short-lived mRNA
- (2009) S. Vispe et al. MOLECULAR CANCER THERAPEUTICS
- Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma
- (2008) A. Zollinger et al. BLOOD
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma
- (2008) T Stühmer et al. LEUKEMIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started